Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Reality check: primary vascular access creation today.

Jann T, Wyss TR, Gahl B, Kalicki RM, Uehlinger DE, Widmer MK.

Swiss Med Wkly. 2018 Sep 23;148:w14668. doi: 10.4414/smw.2018.14668. eCollection 2018 Sep 10.

2.

Cerebral microembolism in the critically ill with acute kidney injury (COMET-AKI trial): study protocol for a randomized controlled clinical trial.

Erdoes G, Uehlinger DE, Kobel B, Stucki MP, Wiest R, Stueber F, Fankhauser N, Jakob SM, Schefold JC.

Trials. 2018 Mar 21;19(1):189. doi: 10.1186/s13063-018-2561-3.

3.

Increased urinary excretion of kynurenic acid is associated with non-recovery from acute kidney injury in critically ill patients.

Aregger F, Uehlinger DE, Fusch G, Bahonjic A, Pschowski R, Walter M, Schefold JC.

BMC Nephrol. 2018 Feb 26;19(1):44. doi: 10.1186/s12882-018-0841-5.

4.

Novel Bone-Anchored Vascular Access on the Mastoid for Hemodialysis: Concept and Preclinical Trials.

Stieger C, Arnold A, Kruse A, Wiedmer S, Widmer M, Guignard J, Schutz D, Guenat JM, Bachtler M, Caversaccio M, Uehlinger DE, Frey FJ, Hausler R.

IEEE Trans Biomed Eng. 2016 May;63(5):984-990. doi: 10.1109/TBME.2015.2480241. Epub 2015 Sep 18.

PMID:
26394413
5.

Risk Behavior and Reciprocity of Organ Donation Attitudes in Young Men.

Vetterli DC, Lava SA, Essig S, Milosevic G, Cajöri G, Uehlinger DE, Moor MB.

Transplant Proc. 2015 Jul-Aug;47(6):1560-6. doi: 10.1016/j.transproceed.2015.02.024.

6.

[A new bone anchored hemodialysis access].

Arnold A, Kruse A, Wiedmer S, Widmer M, Guignard J, Schütz D, Guenat JM, Bachtler M, Caversaccio M, Uehlinger DE, Frey FJ, Häusler R, Stieger C.

Ther Umsch. 2015 Aug;72(8):519-24. doi: 10.1024/0040-5930/a000709. German.

PMID:
26227980
7.

[Renal replacement therapies – Past, present and future].

Kalicki RM, Eicken S, Dahdal S, Uehlinger DE.

Ther Umsch. 2015 Aug;72(8):513-8. doi: 10.1024/0040-5930/a000708. German.

PMID:
26227979
8.

[Editorial. Prostheses and organ replacement].

Uehlinger DE, Vögelin E.

Ther Umsch. 2015 Aug;72(8):485-6. doi: 10.1024/0040-5930/a000705. German. No abstract available.

PMID:
26227975
9.

Clinical Validation of a Peritoneal Dialysis Prescription Model in the PatientOnLine Software.

Hodzic E, Rasic S, Klein C, Covic A, Unsal A, Cunquero JM, Prischl FC, Gauly A, Kalicki RM, Uehlinger DE.

Artif Organs. 2016 Feb;40(2):144-52. doi: 10.1111/aor.12526. Epub 2015 Jul 6.

PMID:
26147618
10.

DETECTION OF MALNUTRITION IN PATIENTS UNDERGOING MAINTENANCE HAEMODIALYSIS: A QUANTITATIVE DATA ANALYSIS ON 12 PARAMETERS.

Nafzger S, Fleury LA, Uehlinger DE, Plüss P, Scura N, Kurmann S.

J Ren Care. 2015 Sep;41(3):168-76. doi: 10.1111/jorc.12125. Epub 2015 Apr 21.

PMID:
25899894
11.

Dynamics of red blood cells in microporous membranes.

Czerwinska J, Rieger M, Uehlinger DE.

Biomicrofluidics. 2014 Jul 2;8(4):044101. doi: 10.1063/1.4886967. eCollection 2014 Jul.

12.

Hemodynamics and flow characteristics of a new dialysis port.

Guignard J, Terefe MB, Uehlinger DE, Czerwinska J.

ASAIO J. 2014 Jan-Feb;60(1):81-9. doi: 10.1097/MAT.0000000000000015.

13.

Identification of IGFBP-7 by urinary proteomics as a novel prognostic marker in early acute kidney injury.

Aregger F, Uehlinger DE, Witowski J, Brunisholz RA, Hunziker P, Frey FJ, Jörres A.

Kidney Int. 2014 Apr;85(4):909-19. doi: 10.1038/ki.2013.363. Epub 2013 Sep 25.

14.

The Validation of a New Visual Anaemia Evaluation Tool HemoHue HH1 in Patients with End-Stage Renal Disease.

Kalicki RM, Farese S, Uehlinger DE.

Anemia. 2013;2013:424076. doi: 10.1155/2013/424076. Epub 2013 Apr 8.

15.

Arterial stiffness depends on serum ionized calcium levels during dialysis with regional citrate anticoagulation.

Moor MB, Kruse A, Uehlinger DE, Eisenberger U.

Artif Organs. 2013 May;37(5):467-74. doi: 10.1111/aor.12037. Epub 2013 Mar 15.

PMID:
23495916
16.

Randomized, double-blind trial of the effect of fluid composition on electrolyte, acid-base, and fluid homeostasis in patients early after subarachnoid hemorrhage.

Lehmann L, Bendel S, Uehlinger DE, Takala J, Schafer M, Reinert M, Jakob SM.

Neurocrit Care. 2013 Feb;18(1):5-12. doi: 10.1007/s12028-012-9764-3.

17.

Modeling of red blood cell life-spans in hematologically normal populations.

Lledó-García R, Kalicki RM, Uehlinger DE, Karlsson MO.

J Pharmacokinet Pharmacodyn. 2012 Oct;39(5):453-62. doi: 10.1007/s10928-012-9261-5. Epub 2012 Jul 31.

PMID:
22847734
18.

Forced fluid removal in critically ill patients with acute kidney injury.

Ganter CC, Hochuli R, Bossard M, Etter R, Takala J, Uehlinger DE, Jakob SM.

Acta Anaesthesiol Scand. 2012 Oct;56(9):1183-90. doi: 10.1111/j.1399-6576.2012.02734.x. Epub 2012 Jul 26.

PMID:
22834537
19.

Haemodialysis in massive caffeine intoxication.

Fausch K, Uehlinger DE, Jakob S, Pasch A.

Clin Kidney J. 2012 Apr;5(2):150-152. doi: 10.1093/ckj/sfs020.

20.

Donor effect on cortical perfusion intensity in renal allograft recipients: a paired kidney analysis.

Marti E, Bergmann IP, Uehlinger DE, Frey FJ, Eisenberger U.

Am J Nephrol. 2011;33(6):530-6. doi: 10.1159/000328383. Epub 2011 May 23.

PMID:
21606644
21.

Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers.

Farese S, Stauffer E, Kalicki R, Hildebrandt T, Frey BM, Frey FJ, Uehlinger DE, Pasch A.

Clin J Am Soc Nephrol. 2011 Jun;6(6):1447-55. doi: 10.2215/CJN.10241110. Epub 2011 May 12.

22.

Quality of life 9 years after an intensive care unit stay: a long-term outcome study.

Stricker KH, Sailer S, Uehlinger DE, Rothen HU, Zuercher Zenklusen RM, Frick S.

J Crit Care. 2011 Aug;26(4):379-87. doi: 10.1016/j.jcrc.2010.11.004. Epub 2011 Mar 3.

PMID:
21376519
23.

Velocity recovery cycles of human muscle action potentials in chronic renal failure.

Z'Graggen WJ, Aregger F, Farese S, Humm AM, Baumann C, Uehlinger DE, Bostock H.

Clin Neurophysiol. 2010 Jun;121(6):874-81. doi: 10.1016/j.clinph.2010.01.024. Epub 2010 Feb 23.

PMID:
20181515
24.

Urinary proteomics before and after extracorporeal circulation in patients with and without acute kidney injury.

Aregger F, Pilop C, Uehlinger DE, Brunisholz R, Carrel TP, Frey FJ, Frey BM.

J Thorac Cardiovasc Surg. 2010 Mar;139(3):692-700. doi: 10.1016/j.jtcvs.2009.11.015.

25.

Glycyrrhetinic acid food supplementation lowers serum potassium concentration in chronic hemodialysis patients.

Farese S, Kruse A, Pasch A, Dick B, Frey BM, Uehlinger DE, Frey FJ.

Kidney Int. 2009 Oct;76(8):877-84. doi: 10.1038/ki.2009.269. Epub 2009 Jul 29.

26.

Treatment of acute renal failure in the intensive care unit: lower costs by intermittent dialysis than continuous venovenous hemodiafiltration.

Farese S, Jakob SM, Kalicki R, Frey FJ, Uehlinger DE.

Artif Organs. 2009 Aug;33(8):634-40. doi: 10.1111/j.1525-1594.2009.00794.x. Epub 2009 Jun 28.

PMID:
19624581
27.

Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients.

Evison J, Farese S, Seitz M, Uehlinger DE, Furrer H, Mühlemann K.

Clin Infect Dis. 2009 May 15;48(10):1402-12. doi: 10.1086/598193.

28.

Red cell survival in relation to changes in the hematocrit: more important than you think.

Kalicki RM, Uehlinger DE.

Blood Purif. 2008;26(4):355-60. doi: 10.1159/000133838. Epub 2008 May 20.

PMID:
18493121
29.

Effect of transcutaneous electrical muscle stimulation and passive cycling movements on blood pressure and removal of urea and phosphate during hemodialysis.

Farese S, Budmiger R, Aregger F, Bergmann I, Frey FJ, Uehlinger DE.

Am J Kidney Dis. 2008 Oct;52(4):745-52. doi: 10.1053/j.ajkd.2008.03.017. Epub 2008 May 19.

PMID:
18487001
30.

Red blood cell lifespan, erythropoiesis and hemoglobin control.

Kruse A, Uehlinger DE, Gotch F, Kotanko P, Levin NW.

Contrib Nephrol. 2008;161:247-254. doi: 10.1159/000130698. Review.

PMID:
18451684
31.

Prophylactic use of hemodialysis to prevent radiocontrast-induced nephropathy: the discussion is open again!

Uehlinger DE.

J Am Coll Cardiol. 2008 Mar 11;51(10):1047-8; author reply 1048. doi: 10.1016/j.jacc.2007.10.051. No abstract available.

32.

Use of the pentasaccharide fondaparinux as an anticoagulant during haemodialysis.

Kalicki RM, Aregger F, Alberio L, Lämmle B, Frey FJ, Uehlinger DE.

Thromb Haemost. 2007 Dec;98(6):1200-7.

PMID:
18064314
33.
34.

Comparison of continuous and intermittent renal replacement therapy for acute renal failure.

Uehlinger DE, Jakob SM, Ferrari P, Eichelberger M, Huynh-Do U, Marti HP, Mohaupt MG, Vogt B, Rothen HU, Regli B, Takala J, Frey FJ.

Nephrol Dial Transplant. 2005 Aug;20(8):1630-7. Epub 2005 May 10.

PMID:
15886217
35.

Outcome of home haemodialysis patients: a case-cohort study.

Saner E, Nitsch D, Descoeudres C, Frey FJ, Uehlinger DE.

Nephrol Dial Transplant. 2005 Mar;20(3):604-10. Epub 2005 Jan 21.

PMID:
15665030
36.

A new Bayesian method to forecast and fine tune individual hemodialysis dose.

Pfister M, Uehlinger DE, Hung AM, Schaedeli F, Sheiner LB.

Hemodial Int. 2004 Jul 1;8(3):244-56. doi: 10.1111/j.1492-7535.2004.01102.x.

PMID:
19379424
37.

The willingness of patients to accept an additional mortality risk in order to improve renal graft survival.

Girardi V, Schaedeli F, Marti HP, Frey FJ, Uehlinger DE.

Kidney Int. 2004 Jul;66(1):375-82.

38.

Epithelial sodium channel (ENaC) subunit mRNA and protein expression in rats with puromycin aminonucleoside-induced nephrotic syndrome.

Audigé A, Yu ZR, Frey BM, Uehlinger DE, Frey FJ, Vogt B.

Clin Sci (Lond). 2003 Apr;104(4):389-95.

PMID:
12653683
39.

Smoking and dialysis: a dreadful scenario for the cardiovascular system?

Orth SR, Uehlinger DE.

Kidney Int. 2003 Apr;63(4):1580-1. Review. No abstract available.

40.

Medical futility: predicting outcome of intensive care unit patients by nurses and doctors--a prospective comparative study.

Frick S, Uehlinger DE, Zuercher Zenklusen RM.

Crit Care Med. 2003 Feb;31(2):456-61.

PMID:
12576951
41.

Assessment of former ICU patients' quality of life: comparison of different quality-of-life measures.

Frick S, Uehlinger DE, Zürcher Zenklusen RM.

Intensive Care Med. 2002 Oct;28(10):1405-10. Epub 2002 Jul 26.

PMID:
12373464
42.

DNR orders at a tertiary care hospital--are they appropriate?

Vetsch G, Uehlinger DE, Zuercher-Zenklusen RM.

Swiss Med Wkly. 2002 Apr 20;132(15-16):190-6.

PMID:
12070784
43.

Allometric scaling and maximum efficiency in physiological eigen time.

Andresen B, Shiner JS, Uehlinger DE.

Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):5822-4. Epub 2002 Apr 16.

44.

Body mass index: a measure for longevity.

Shiner JS, Uehlinger DE.

Med Hypotheses. 2001 Dec;57(6):780-3.

PMID:
11918447
45.
46.

Glycyrrhetinic acid decreases plasma potassium concentrations in patients with anuria.

Serra A, Uehlinger DE, Ferrari P, Dick B, Frey BM, Frey FJ, Vogt B.

J Am Soc Nephrol. 2002 Jan;13(1):191-6.

47.

Biological scaling and Kt/V: additional aspects.

Shiner JS, Uehlinger DE.

Am J Kidney Dis. 2000 Aug;36(2):447-8. No abstract available.

PMID:
10922327
48.

[Which hypertensive patient requires diuretic therapy?].

Ferrari P, Uehlinger DE.

Ther Umsch. 2000 Jun;57(6):380-5. Review. German.

PMID:
10894023
49.

Novel dialysis cannulas: are they worth the higher price tag?

Pfister M, Schädeli F, Bühler M, Frey FJ, Uehlinger DE.

Am J Kidney Dis. 2000 Apr;35(4):624-8.

PMID:
10739782
50.

Pharmacokinetics and haemodynamics of candesartan cilexetil in hypertensive patients on regular haemodialysis.

Pfister M, Schaedeli F, Frey FJ, Uehlinger DE.

Br J Clin Pharmacol. 1999 Jun;47(6):645-51.

Supplemental Content

Loading ...
Support Center